Fig. 2.
Genetic mutation mapping of the VM genes. (A-B) Mutation frequency of the VM genes. (C) Correlation between VM genes methylation and mRNA expression. (D) Survival differences between hypermethylation and hypomethylation of the VM genes in breast cancer. (E) Correlation between GDSC drug sensitivity and mRNA expression of the VM genes. (F) Activation or inhibition of 10 major tumor-related pathways by VM gene expression levels.